October 8, 2021 -- Stacy Lindborg, PhD, executive vice president and head of global clinical research at BrainStorm Cell Therapeutics, will deliver a presentation at the 2021 Cell & Gene Meeting on the Mesa, held October 12-14 in Carlsbad, CA, and virtually October 19-20.
Lindborg will discuss the expansion of Brainstorm's technology portfolio, which includes autologous and allogeneic product candidates covering multiple neurological diseases. The company completed a phase III trial of NurOwn in amyotrophic lateral sclerosis patients, according to the company.
The presentation will be available as an on-demand webinar that will be available beginning October 12. At the conclusion of the meeting, a copy of the presentation will also be available in the Investors and Media section of the BrainStorm website under Events and Presentations.
Copyright © 2021 scienceboard.net